Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India: Sources

India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's Covid-19 vaccine for restricted emergency use in the country, official sources said on Tuesday. Moderna's vaccine will be the fourth Covid-19 jab to be available in India after Covishield, Covaxin and Sputnik.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3x8soEG
https://ift.tt/3h1yRLH